Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 415)
Posted On: 05/19/2019 1:15:06 PM
Post# of 72445
Avatar
Posted By: Drano
Why bother the CEO with an email asking whether the press release, which clearly stated that the term sheet was for "Ulcerative Proctitis/Proctosigmoiditis," meant that it was for ulcerativeproctitis/proctosigmoiditis, and not other things?

OF COURSE oral mucositis was not involved in the term sheet. The claim that it was included was part of the false narrative of the bashers. And then when they realized that no one was buying their story, or maybe when they decided that they have monopolized message boards enough with that nonsense, some of them changed their false narrative to "no one wants the OM formulation" which is an absurd and desperate twisting of the information that we have.

None of us wrote the CEO with an inquiry because we knew IT WAS NOT NECESSARY.















(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site